Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06626139Phase 2Recruiting
Phase 2, randomised, double-blind trial of psilocybin in psychological well-being (4 arms). Primary endpoints: Challenging Experience Questionnaire, Warwick-Edinburgh Mental Wellbeing Scale and 2 more. Started Oct 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06626139.